Skip to main content
Terence Flotte, MD, Pediatric Pulmonology, Worcester, MA, UMass Memorial Medical Center

TerenceRFlotteMD

Pediatric Pulmonology • Worcester, MA

Professor, Pediatrics, University Massachusetts Medical School

Join to view full profile

Dr. Flotte is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Flotte's full profile

Already have an account?

  • Office

    55 Lake Ave N
    Department Of Pediatric Pulmonary Medicine
    Worcester, MA 01655
    Phone+1 508-334-4155
    Fax+1 508-856-2609
  • Is this information wrong?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Pulmonology, 1989 - 1992
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1986 - 1989
  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2007 - 2024
  • FL State Medical License
    FL State Medical License 1996 - 2010
  • MD State Medical License
    MD State Medical License 1987 - 1996
  • LA State Medical License
    LA State Medical License 1986 - 1991
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Pulmonology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Top Story: UMass Chan Launches Translational Institute for Molecular Therapeutics
    Top Story: UMass Chan Launches Translational Institute for Molecular TherapeuticsDecember 27th, 2022
  • Cure Rare Disease Receives FDA Approval to Administer First-in-Human CRISPR Therapeutic
    Cure Rare Disease Receives FDA Approval to Administer First-in-Human CRISPR TherapeuticAugust 10th, 2022
  • FDA Advisers Offer a Vote of Confidence for Gene Therapies
    FDA Advisers Offer a Vote of Confidence for Gene TherapiesJune 19th, 2022
  • Join now to see all

Grant Support

  • Preclinical &Phase I/II Trials Of Aav-Aat VectorsNational Heart, Lung, And Blood Institute2007–2011
  • Liver-Directed Gene Therapy For Alpha 1 Antitrypsin (AAT) DeficiencyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Expression System With Adeno-Associated Viral VectorsNational Heart, Lung, And Blood Institute2004–2008
  • L2762g Eff Of Nutropin AQ For Trmt Of Growth Restriction In Child W CFNational Center For Research Resources2006–2007
  • Phase I Trial Of Intramuscular Injection Of A Recombinant Adeno-Associated VirusNational Center For Research Resources2005–2007
  • Preclinical &Phase I/II Trials Of Aav-Aat VectorsNational Heart, Lung, And Blood Institute2003–2007
  • Establishment Of Ngvl Toxicology LAB: Raav Vectors, Cystic FibrosisNational Center For Research Resources2004–2006
  • Recombinant AAV For Correction Of Genetic AbnormalitiesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2006
  • Administrative CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • AAV Vector Delivery To Skeletal Muscle, Platform For Therapeutic Protein DeliveryNational Heart, Lung, And Blood Institute2002–2005
  • Molecular Therapies For A1a Liver Disease. Sub: Estab Cell Lines For LAB InvNational Center For Research Resources2004
  • Ngvl Toxicology LaboratoryNational Center For Research Resources2001–2004
  • Ngvl Toxicology LaboratoryNational Center For Research Resources2003
  • Gene Therapy For Liver And Lung DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Adeno-Associated Virus Vectors For Cystic Fibrosis Gene TherapyNational Heart, Lung, And Blood Institute1996–2002
  • AAV Vector Delivery To Skeletal Muscle--Therapeutic Protein Delivery PlatformNational Heart, Lung, And Blood Institute1997–2001
  • Phase I Study--Adeno Associated Virus CFTR Gene Vector In Adult Cystic FibrosisNational Center For Research Resources1997–2001
  • Effects Of Nicotine Nasal Spray Device On Cardiovascular &PulmonaryNational Center For Research Resources1999–2000
  • Effects Of Nicotine Nasal Spray Devices On Pulmonary And Cardiovascular FunctionNational Center For Research Resources1998–1999
  • Strategies To Improve AAV CFTR Persistence &ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
  • AAV Vector Delivery To Skeletal Muscle--Therapeutic Protein Delivery PlatformNational Heart, Lung, And Blood Institute1998

Hospital Affiliations

Dr. Terence Flotte, Dr. Terence Flotte, MD, Dr. T Flotte, Dr. Terence R Flotte